Myles, who previously worked at National Institutes of Health, shared how the new administration has impacted the federal agency’s communications.

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

America has a medical bureaucracy problem that’s slowing the adoption of vital preventative technologies, writes Kevin ...

Dr. Sandro Galea, a distinguished professor in public health and dean of the Washington University School of Public Health, warns that the administration's turn toward alternative medicine risks ...

A transparent chip no larger than a stick of gum is helping scientists at the University of Tennessee Health Science Center, ...

Kurt Ribisl will be the next dean of the IU School of Public Health-Bloomington, according to a news release Monday from the ...